default image

Belegabteilung für Urologie

Information and services of the department

  • Number of inpatient cases: 191

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 49
Hyperplasia of prostate (N40) 26
Calculus of kidney and ureter - Calculus of ureter (N20.1) 17
Malignant neoplasm of prostate (C61) 16
Malignant neoplasm of bladder - Malignant neoplasm of dome of bladder (C67.1) 7
Inguinal hernia - Unilateral inguinal hernia without obstruction or gangrene not specified as recurrent (K40.90) 7
Other disorders of bladder (N32.8) 7
Neoplasm of uncertain or unknown behaviour of male genital organs - Neoplasm of uncertain behavior of prostate (D40.0) 5
Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) 4
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 4
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 123
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41) 63
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) 49
Examination of the urethra and the urinary bladder by endoscopy (1-661) 38
(1-999.40) 37
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) 28
Removal of stones, foreign bodies or collections of blood from the bladder by endoscopy (5-570.4) 24
Insertion, exchange or removal of a ureteral stent (8-137.00) 18
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 16
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 13

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Number Group
27 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
23 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
20 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Lectureships / teaching posts at colleges and universities
Participation in multi-centre phase III/IV studies
Project-related cooperation with colleges and universities
Doctoral supervision
Student training (clinical traineeship / internship year) Unterricht am Krankenbett
No. Training in other healing professions Comment
HB03 Physical therapist / physiotherapist (m/f)
HB07 Surgical technical assistant (m/f)
HB17 Auxiliary nurse (m/f)
HB01 Nurse and health care worker (m/f)
HB02 Health and paediatric nurse (m/f)

Ronny Schneider

Örtlicher Patientenfürsprecher

Phone: 0203 -451-3690
Mail: ed.nlkve@redienhcs.ynnor

Frank Radefeld

Qualitätsmanagementbeauftragter

Phone: 0203 -508-1435
Mail: ed.nlkve@edrewhcseB

Dr. med. Andreas Sander

Medizinischer Geschäftsführer

Phone: 0203 -508-1500
Mail: ed.nlkve@fgm

Stefan Alexander Simon

Krankenhaushygieniker

Phone: 0203 -508-1599
Mail: ed.nlkve@nomis.rednaxelanafets

Dr. rer. nat. Andreas Grzesiok

Projektleitung Arzneimitteltherapiesicherheit

Phone: 0208 -508-1360
Mail: ed.nlkve@koisezrg.saerdna